Viewing Study NCT00093366


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2026-02-24 @ 3:13 PM
Study NCT ID: NCT00093366
Status: COMPLETED
Last Update Posted: 2011-11-30
First Post: 2004-10-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Sponsor: Fred Hutchinson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 1888.00
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View